Ashley C Solomon1, Dilip Kumar Maurya. 1. Department of General Surgery, Sri Laksmi Narayana Institute of Medical Sciences, Pondicherry, India.
Abstract
INTRODUCTION: Varicose veins are one of the most common vascular problems encountered. Ultrasound guided foam sclerotherapy is one such option it was introduced in 2001. We present our two needle technique of ultrasound guided foam sclerotherapy along with our short term results. MATERIALS AND METHODS: Patients presenting us between January 2009 to October 2009 with symptomatic primary varicose veins were selected for this procedure. Ultrasound guided foam sclerotherapy was done using the two needle technique using sodium tetra decyl sulphate. RESULTS: Fifteen patients and 19 legs were treated. Complete closure of veins was achieved with a single injection at 1 month follow up in 17 legs. One leg required one additional injection and one leg required two injections. No recurrence has been noted at the end of a follow up of 1-6 months. CONCLUSION: Foam sclerotherapy is an effective, less expensive day care procedure with minimal complication rates.
INTRODUCTION: Varicose veins are one of the most common vascular problems encountered. Ultrasound guided foam sclerotherapy is one such option it was introduced in 2001. We present our two needle technique of ultrasound guided foam sclerotherapy along with our short term results. MATERIALS AND METHODS:Patients presenting us between January 2009 to October 2009 with symptomatic primary varicose veins were selected for this procedure. Ultrasound guided foam sclerotherapy was done using the two needle technique using sodium tetra decyl sulphate. RESULTS: Fifteen patients and 19 legs were treated. Complete closure of veins was achieved with a single injection at 1 month follow up in 17 legs. One leg required one additional injection and one leg required two injections. No recurrence has been noted at the end of a follow up of 1-6 months. CONCLUSION: Foam sclerotherapy is an effective, less expensive day care procedure with minimal complication rates.